These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8024198)

  • 21. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.
    Levi S; Urbano-Ispizua A; Gill R; Thomas DM; Gilbertson J; Foster C; Marshall CJ
    Cancer Res; 1991 Jul; 51(13):3497-502. PubMed ID: 1675933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The synthesis and biological activities of oligodeoxynucleotides that are covalently linked to psoralen at their 5' ends.
    Wang LX; Yang DC; Lu YY; Takagi Y; Taira K; Li T; Zhang LH
    Drug Des Discov; 1995 Nov; 13(2):109-21. PubMed ID: 8872455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of oncogenic NRAS by RNA interference induces apoptosis of human melanoma cells.
    Eskandarpour M; Kiaii S; Zhu C; Castro J; Sakko AJ; Hansson J
    Int J Cancer; 2005 May; 115(1):65-73. PubMed ID: 15688405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis and functional studies on nucleic acids. Problems related to synthetic ras genes].
    Ohtsuka E
    Yakugaku Zasshi; 1994 Oct; 114(10):747-64. PubMed ID: 7807379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Ha-ras oncogene transfection does not affect NK cell sensitivity of human colorectal carcinoma cell lines.
    van Ierssel GJ; de Vries JE; Mierement-Ooms MA; van der Zon AM; ten Kate J; Lamers CB; Verspaget HW
    Anticancer Res; 1995; 15(2):349-52. PubMed ID: 7763005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration in the coding potential and expression of H-ras in human cytomegalovirus-transformed cells.
    Boldogh I; Huang ES; Rady P; Arany I; Tyring S; Albrecht T
    Intervirology; 1994; 37(6):321-9. PubMed ID: 8586530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological activity of human N-ras and K-ras genes containing the Asn17 dominant negative mutation.
    Kaplan JB
    Oncol Res; 1994; 6(12):611-5. PubMed ID: 7787254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An anti-K-ras ribozyme suppresses oncogene expression and cell growth of human pancreatic cancer.
    Sakuma T; Kijima H; Nishi M; Abe Y; Yamazaki H; Mine T; Nakamura M; Ueyama Y
    Tokai J Exp Clin Med; 2004 Jun; 29(2):35-42. PubMed ID: 15473338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
    Xu Y; Deng GR; Liang YY; Li C
    Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection].
    Wang Q; Feng X; Lin Z
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):170-2. PubMed ID: 10920888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activation of the human Harvey-ras proto-oncogene by aflatoxin B1.
    Riley J; Mandel HG; Sinha S; Judah DJ; Neal GE
    Carcinogenesis; 1997 May; 18(5):905-10. PubMed ID: 9163674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of the oncogene N-ras on cell cycle delay in a human melanoma cell line with reduced radioresistance.
    Pomp J; Ouwerkerk IJ; Hoogstraten C; Wondergem J; Davelaar J; Leer JW; Schrier PI
    Oncol Rep; 2000; 7(3):663-7. PubMed ID: 10767387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma.
    Tsuchida T; Kijima H; Hori S; Oshika Y; Tokunaga T; Kawai K; Yamazaki H; Ueyama Y; Scanlon KJ; Tamaoki N; Nakamura M
    Cancer Gene Ther; 2000 Mar; 7(3):373-83. PubMed ID: 10766343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
    Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G
    Cancer Res; 1994 Sep; 54(17):4785-90. PubMed ID: 8062279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.
    Richards CA; Short SA; Thorgeirsson SS; Huber BE
    Cancer Res; 1990 Mar; 50(5):1521-7. PubMed ID: 2154325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models.
    Jansen B; Inoue SA; Wadl H; Eichler HG; Wolff K; Van Elsas A; Schrier PI; Pehamberger H
    Int J Cancer; 1996 Sep; 67(6):821-5. PubMed ID: 8824554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.
    Billadeau D; Jelinek DF; Shah N; LeBien TW; Van Ness B
    Cancer Res; 1995 Aug; 55(16):3640-6. PubMed ID: 7627974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras.
    Scherr M; Maurer AB; Klein S; Ganser A; Engels JW; Grez M
    Gene Ther; 1998 Sep; 5(9):1227-34. PubMed ID: 9930324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
    Kwong YY; Husain Z; Biswas DK
    Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.